ABBV | AbbVie
152.34 2.89 (1.93%)
ABBV Price Profile
$150.89
$152.34
149.62 - 152.74
105.56 - 175.91
256.99B
8.53M
149.45
155.16
1.77B
1.77B
6.22M
0.81
5.00
16.61M
0.81%
1.68
1962.20%
6.97
0.04
25.85B
38.88B
7.57B
73.65B
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
AbbVie (ABBV) company profile
AbbVie Inc. (NYSE: ABBV) is a research company that develops pharmaceutical products. The company offers its products in various therapeutic categories, including immunology, chronic kidney disease, hepatitis C, women’s health, oncology, and neuroscience. AbbVie also provides treatments for specific conditions, including multiple sclerosis, Parkinson’s, and Alzheimer’s.